All Updates

All Updates

icon
Filter
Funding
Sidekick raises USD 55 million in Series B funding
Preventive Healthcare
May 5, 2022
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Preventive Healthcare

Preventive Healthcare

May 5, 2022

Sidekick raises USD 55 million in Series B funding

Funding

  • Digital therapeutics (DTx) startup Sidekicks has raised USD 55 million (EUR 52 million)  in a Series B funding round led by London-based Novator Ventures, with participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a US-based strategic investor. 

  • The funds will be used to expand its chronic disease treatment programs into new therapeutic areas, as well as to form new partnerships and enhance existing ones with players in the healthcare and pharmaceutical industry. Additionally, the company plans to double its headcount to 240 team members. 

  • The B2B2C DTx company is focused on developing personalized programs for patients with chronic conditions - from cancer to heart health -  and other behavioral conditions such as smoking addiction. Its platform offers gamified content that incorporates lifestyle changes and clinical treatments to improve healthcare outcomes. The firm partners with health plans such as Anthem to reach patients and develops DTx solutions with pharma giants including Pfizer and Bayer. It has served over 40,000 patients globally across the US, Germany, Sweden, and Iceland.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.